Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Anti-PLA2R antibody"'
Autor:
Yuanyuan Zhang, Jingjing Yang, Jianzhong Li, Jiani Sun, Ling Zhou, Deyu Xu, Wengang Sha, Lan Dai, Lei Shen
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background The aim of this study was to investigate the effects and significance of rituximab (RTX) on the levels of T lymphocyte subsets in patients diagnosed with primary membranous nephropathy (PMN). Methods A total of 58 PMN patients and
Externí odkaz:
https://doaj.org/article/992af6f1f17546fc9da48bd55a921a04
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Renal biopsy remains the gold standard for diagnosing membranous nephropathy (MN). Recent studies have suggested that renal biopsy can be replaced with the serum phospholipase A2 receptor (PLA2R) antibody test for MN diagnosis in patients wi
Externí odkaz:
https://doaj.org/article/1bf4cbf75a4d43d5b1e5d35631df5673
Autor:
Yan-jiao Cheng, Xiao-yu Jia, Hong-ru Cao, Xiao-yi Zhao, Xu-jie Zhou, Xiao-juan Yu, Rong Xu, Fu-de Zhou, Su-xia Wang, Zhao Cui, Ming-hui Zhao
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-5 (2023)
Abstract Background The phospholipase A2 receptor (PLA2R) associated with membranous nephropathy (MN) is an organ-specific autoimmune disease associated with PLA2R and human leukocyte antigen (HLA) genes. Familial PLA2R-related MN is rarely reported.
Externí odkaz:
https://doaj.org/article/3d9324bf78c9475988e8509ca9f1b9de
Publikováno v:
International Journal of General Medicine, Vol Volume 16, Pp 1879-1889 (2023)
Jiayi Li,1,2 Jiao Zhang,2 Xu Wang,2 Xumin Zheng,2 Hongmei Gao,2 Shimin Jiang,2 Wenge Li1,2 1Department of Nephrology, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, People’s Republic of China; 2Department of Nephrolo
Externí odkaz:
https://doaj.org/article/cb1a6eaeca9c4046b0db25f7b73e02b5
Autor:
Ying Zhang, Ping Chen, Baobao Wang, Xueqing Tang, Yong Wei, Wei Cao, Lijun Tang, Zunsong Wang, Na Zhao
Publikováno v:
Renal Failure, Vol 45, Iss 2 (2023)
Background Idiopathic membranous nephropathy is widely recognized as an autoimmune kidney disease that is accompanied by the discovery of several autoantibodies, and the antibody subclass in the circulation of patients with iMN is mainly IgG. However
Externí odkaz:
https://doaj.org/article/bffa58d4223648e6bc9c3ae3b3946f13
Publikováno v:
Renal Failure, Vol 45, Iss 2 (2023)
Serum anti-phospholipase A2 receptor (anti-PLA2R) antibody is used for the noninvasive diagnosis of idiopathic membranous nephropathy (IMN). However, the cutoff value of anti-PLA2R antibodies in IMN patients is debatable. This study aimed to investig
Externí odkaz:
https://doaj.org/article/dd06ee3931d943bf8d99b51448318012
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Thyroid dysfunction is common in patients with nephrotic syndrome, especially patients with primary membranous nephropathy (pMN). In view of both MN and thyroid dysfunction are associated with autoimmunity, the current study aimed
Externí odkaz:
https://doaj.org/article/33cd0581daad42ba99ed0c0052503057
Publikováno v:
Renal Failure, Vol 44, Iss 1, Pp 594-600 (2022)
Background Primary membranous nephropathy (PMN) is associated with the highest risk for developing venous thrombosis compared with other nephrotic diseases. The aim of the study was to assess the predictive value of the pathognomonic anti-phospholipa
Externí odkaz:
https://doaj.org/article/50156f53c42b4076b1213a6a2221c36c
Publikováno v:
Renal Failure, Vol 44, Iss 1, Pp 304-313 (2022)
Background The pathogenesis of primary membranous nephropathy (MN) involves the antibodies against antigens on the cell surface of podocytes, with the majority of M-type phospholipase A2 receptor (PLA2R), and a profound podocyte dysfunction. The effe
Externí odkaz:
https://doaj.org/article/3faa5c37896346f3a5832303cc713531
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.